RWM
TEVA icon

Reston Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Reston Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000
Closed -$18K – 383
2024
Q3 		$18K Buy
+1,000
New +$17.5K 0.01% 200

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Reston Wealth Management's TEVA Position: Q4 2024 in Review

Reston Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2024, closing a stake of 1,000 shares — an estimated $18K sold.

Reston Wealth Management first reported a position in TEVA in Q3 2024 and held it in 1 quarter. The position peaked at $18K in Q3 2024. 585 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Reston Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2024 after selling out during the quarter.
  • Reston Wealth Management sold 1,000 Teva Pharmaceutical Industries Limited shares in Q4 2024, an estimated $18K.
  • Reston Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2024 and held it in 1 quarter.
  • Reston Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $18K in Q3 2024.
  • 585 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2024.

Based on Reston Wealth Management's 13F filing for Q4 2024, filed 23 Jan 2025.